Profile | GDS2987 / GI_38016940-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 86.6 | 75 |
GSM215244 | HMVEC_vehicle_rep2 | 107 | 76 |
GSM215253 | HMVEC_vehicle_rep3 | 70.4 | 73 |
GSM215254 | HMVEC_atorvastatin_rep1 | 140.3 | 79 |
GSM215282 | HMVEC_atorvastatin_rep3 | 160.3 | 80 |
GSM215344 | HMVEC_atorvastatin_rep2 | 114 | 77 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 17 | 32 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 25.9 | 46 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 111.2 | 76 |
GSM215294 | HMVEC_SLx2119_rep1 | 36.3 | 67 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 20.9 | 34 |
GSM215297 | PASMC_vehicle_rep1 | 291.1 | 84 |
GSM215298 | PASMC_vehicle_rep2 | 368.3 | 86 |
GSM215310 | PASMC_vehicle_rep3 | 261.5 | 84 |
GSM215311 | PASMC_atorvastatin_rep1 | 544.8 | 90 |
GSM215312 | PASMC_atorvastatin_rep2 | 411.4 | 87 |
GSM215313 | PASMC_atorvastatin_rep3 | 457.4 | 88 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 395.3 | 87 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 437.8 | 88 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 469.9 | 88 |
GSM215327 | PASMC_SLx2119_rep1 | 219.1 | 82 |
GSM215328 | PASMC_SLx2119_rep2 | 192.4 | 81 |
GSM215329 | PASMC_SLx2119_rep3 | 186.2 | 80 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 6.9 | 23 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 17.3 | 42 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 20.2 | 48 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 14.4 | 34 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 12.8 | 39 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 3.1 | 10 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | 5.5 | 16 |
GSM215341 | Fibroblasts_SLx2119_rep3 |